Skip to content

Dr. Lal Path Labs Ltd.

LALPATHLAB · 539524 · Healthcare · Healthcare Service Provider

Full report
Rs 1,911.7−10.6 (−0.55%)
Market cap
Rs 32,040 Cr
P/E
58.90x
P/B
12.77x
52W high / low
Rs 2,038.6 / Rs 1,272.6

About Dr. Lal Path Labs

Dr. Lal Path Labs Ltd. is listed on the NSE under the symbol LALPATHLAB and on the BSE under scrip code 539524. It is classified in the Healthcare sector, industry: Healthcare Service Provider. It is a constituent of BSE 500, NIFTY 500 and NIFTY Smallcap 250. The company listed on 23 Dec 2015 and has a face value of Rs 10.

The latest available end-of-day price is Rs 1,911.7 (−0.55% on the day), for a market capitalisation of Rs 32,040 Cr. Trailing P/E is 58.90x and price-to-book is 12.77x. The 52-week range is Rs 1,272.6 to Rs 2,038.6. The latest price is 83% of the way from the 52-week low to the 52-week high.

Latest annual results

For Q1 FY27 (period ended 30 Jun 2026), Dr. Lal Path Labs Ltd. reported revenue of Rs 798 Cr, net profit of Rs 171 Cr and earnings per share of Rs 10.15.

On a trailing-twelve-month basis the filings add up to revenue of Rs 2,891 Cr, net income of Rs 546 Cr and a net margin of 18.90%.

Shareholding pattern

In the shareholding pattern for 30 Sept 2026, Dr. Lal Path Labs Ltd.'s ownership is split: promoters 52.93%; foreign institutional investors (FIIs) 18.73%; domestic institutional investors (DIIs) 21.58%; retail and other shareholders 6.35%.

Compared with the filing for 30 Jun 2026: promoter holding −0.26 percentage points; FII holding +1.37 percentage points; DII holding −0.01 percentage points.

The same filing lists reported promoter pledge of 0.00% and 1,13,559 shareholders on record.

Figures are raw disclosures from official NSE/BSE and SEBI filings plus mechanically computed ratios, restated in words. This is research data, not investment advice, a rating or a recommendation; DalalOS is not a SEBI-registered investment advisor.

More
Loading stock details

Companies are grouped mechanically from the exchange classification and listed by market capitalisation. This is a comparison set, not a ranking or recommendation.

Explore further

Dr. Lal Path Labs (LALPATHLAB) share price & financials · DalalOS